Cargando…
SUN-044 Gonadotropin Releasing Hormone (GnRH) Agonist Therapy Induces a Sustained Reduction in Plasma Testosterone Levels and Is Well Tolerated in Transwomen Veterans
Gender affirming hormone therapy (GAHT) is the mainstay of long-term management of transgender individuals. In transwomen, treatment with physiologic doses of estrogen alone is often insufficient to suppress testosterone to the desired level. Although GnRH agonist therapy is usually prescribed for p...
Autores principales: | Gondin, Lyan, Trejo, Jonathan, Pinkson, Sheila, chen, xi, Case, Emina, Wortham, Joy, koops, Maureen, Tripathy, Devjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209546/ http://dx.doi.org/10.1210/jendso/bvaa046.1575 |
Ejemplares similares
-
SAT403 Long-term Metabolic Effects Of Gonadotropin Releasing Hormone Agonist (GnRH) Therapy In Transgender Women Veterans
por: Le, Guillaume, et al.
Publicado: (2023) -
MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria
por: Mok, Mary, et al.
Publicado: (2019) -
Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017) -
Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023) -
FRI419 Progesterone Regulation Of The GnRH Pulse Generator
por: Wall, Ellen Gabrielle
Publicado: (2023)